{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:45Z","timestamp":1792813245006,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":1995,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.joca.2008.03.001","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T09:21:22Z","timestamp":1208251282000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? \u2013 a meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"16","author":[{"given":"R.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Astrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bliddal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9463","key":"10.1016\/j.joca.2008.03.001_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(05)71086-2","article-title":"Pathogenesis and management of pain in osteoarthritis","volume":"365","author":"Dieppe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2008.03.001_bib2","first-page":"10","article-title":"Criteria for classification of clinical osteoarthritis","volume":"27","author":"Altman","year":"1991","journal-title":"J Rheumatol Suppl"},{"issue":"8","key":"10.1016\/j.joca.2008.03.001_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2008.03.001_bib4","first-page":"70","article-title":"Inflammation in osteoarthritis","volume":"70","author":"Abramson","year":"2004","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.1780400419","article-title":"Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease","volume":"40","author":"Spector","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.joca.2008.03.001_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/ard.2004.028886","article-title":"EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"64","author":"Zhang","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.joca.2004.01.006","article-title":"Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis","volume":"12","author":"Abadie","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib9","first-page":"799","article-title":"Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III","volume":"24","author":"Bellamy","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2008.03.001_bib10","series-title":"Evidence-Based Rheumatology","author":"Tugwell","year":"2004"},{"issue":"Suppl A","key":"10.1016\/j.joca.2008.03.001_bib11","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.joca.2003.09.009","article-title":"Monitoring osteoarthritis progression and therapy","volume":"12","author":"Dougados","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ptr.1729","article-title":"The evidence for clinical efficacy of rose hip and seed: a systematic review","volume":"20","author":"Chrubasik","year":"2006","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib13","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2016","article-title":"Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence","volume":"8","author":"Ameye","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10787-999-0026-8","article-title":"The anti-inflammatory properties of rose-hip","volume":"7","author":"Winther","year":"1999","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10787-999-0031-y","article-title":"Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo","volume":"7","author":"Kharazmi","year":"1999","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/j.joca.2008.03.001_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/np0300636","article-title":"An antiinflammatory galactolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro","volume":"66","author":"Larsen","year":"2003","journal-title":"J Nat Prod"},{"key":"10.1016\/j.joca.2008.03.001_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jep.2007.03.029","article-title":"In vivo anti-inflammatory and antinociceptive activity of the crude extract and fractions from Rosa canina L. fruits","volume":"112","author":"Orhan","year":"2007","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"10.1016\/j.joca.2008.03.001_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ptr.2236","article-title":"COX-1 and -2 activity of rose hip","volume":"21","author":"Jager","year":"2007","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/03009740510018624","article-title":"A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial","volume":"34","author":"Winther","year":"2005","journal-title":"Scand J Rheumatol"},{"issue":"9193","key":"10.1016\/j.joca.2008.03.001_bib20","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib22","first-page":"768","article-title":"Measurement of pain","volume":"9","author":"Huskisson","year":"1982","journal-title":"J Rheumatol"},{"issue":"Suppl II","key":"10.1016\/j.joca.2008.03.001_bib23","first-page":"495","article-title":"Rose-hip in osteoarthritis (OA): a meta-analysis","volume":"66","author":"Christensen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"15","key":"10.1016\/j.joca.2008.03.001_bib25","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/sim.1207","article-title":"Meta-analysis combining parallel and cross-over clinical trials. III: the issue of carry-over","volume":"21","author":"Curtin","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.joca.2008.03.001_bib26","series-title":"Analysing and Presenting Results","first-page":"97","year":"2005"},{"issue":"7382","key":"10.1016\/j.joca.2008.03.001_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.joca.2008.03.001_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","article-title":"Meta-analysis: formulating, evaluating, combining, and reporting","volume":"18","author":"Normand","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.joca.2008.03.001_bib29","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1016\/j.joca.2008.03.001_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass's estimator of effect size and related estimators","volume":"6","author":"Hedges","year":"1981","journal-title":"J Educational Statistics"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"Suppl 3","key":"10.1016\/j.joca.2008.03.001_bib32","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/00005650-198903001-00015","article-title":"Effect sizes for interpreting changes in health status","volume":"27","author":"Kazis","year":"1989","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.joca.2008.03.001_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.2006.062091","article-title":"EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"66","author":"Zhang","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7247","key":"10.1016\/j.joca.2008.03.001_bib34","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","article-title":"Statistics notes: the odds ratio","volume":"320","author":"Bland","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2008.03.001_bib35","series-title":"SAS for Mixed Models","author":"Littell","year":"2006"},{"issue":"3","key":"10.1016\/j.joca.2008.03.001_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/biomet\/58.3.545","article-title":"Recovery of inter-block information when block sizes are unequal","volume":"58","author":"Patterson","year":"1971","journal-title":"Biometrika"},{"key":"10.1016\/j.joca.2008.03.001_bib37","series-title":"Integrating Results through Meta-Analytic Review Using SAS Software","author":"Wang","year":"1999"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/sim.1040","article-title":"Advanced methods in meta-analysis: multivariate approach and meta-regression","volume":"21","author":"van Houwelingen","year":"2002","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"11","key":"10.1016\/j.joca.2008.03.001_bib40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"10.1016\/j.joca.2008.03.001_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2008.03.001_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.62.4.316","article-title":"Number needed to treat (NNT): implication in rheumatology clinical practice","volume":"62","author":"Osiri","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.joca.2008.03.001_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03009740701607067","article-title":"The number needed to treat for adalimumab, etanercept and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review","volume":"36","author":"Kristensen","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.joca.2008.03.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-1","article-title":"Simpson's paradox and calculation of number needed to treat from meta-analysis","volume":"2","author":"Cates","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.joca.2008.03.001_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-2-3","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2","author":"Altman","year":"2002","journal-title":"BMC Med Res Methodol"},{"issue":"7341","key":"10.1016\/j.joca.2008.03.001_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.324.7341.827","article-title":"Explaining risks: turning numerical data into meaningful pictures","volume":"324","author":"Edwards","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2008.03.001_bib48","series-title":"Version 1.0\u20131.7. Copyright\u00a9 2000\u20132003","author":"Visual Rx","year":"2003"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib49","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1572-0241.2000.02015.x","article-title":"Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome","volume":"95","author":"Nobaek","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.joca.2008.03.001_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-2001-15685","article-title":"Value of complementary medicine exemplified by rose-hips","volume":"63","author":"Rossnagel","year":"2001","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.joca.2008.03.001_bib51","unstructured":"Rein E. Hansen OT, Hansen M, Assignee. Composition and method for alleviating joint pain and stiffness. United States Patent. Patent US 6,485,752 B1. 2002 Nov 26."},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0011-393X(03)00004-3","article-title":"The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"64","author":"Warholm","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phymed.2004.01.001","article-title":"A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis \u2013 a double-blind, placebo-controlled, randomised trial","volume":"11","author":"Rein","year":"2004","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.joca.2008.03.001_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ncprheum0093","article-title":"Complementary or alternative therapies for osteoarthritis","volume":"2","author":"Ernst","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7","key":"10.1016\/j.joca.2008.03.001_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ptr.2142","article-title":"Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain","volume":"21","author":"Chrubasik","year":"2007","journal-title":"Phytother Res"},{"key":"10.1016\/j.joca.2008.03.001_bib56","series-title":"SAS for Monte Carlo Studies: a Guide for Quantitative Researchers","author":"Fan","year":"2001"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib57","first-page":"131","article-title":"A survey of exact inference for contingency tables","volume":"7","author":"Agresti","year":"1992","journal-title":"Stat Sci"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2307\/2346643","article-title":"Algorithm AS 36: exact confidence limits for the odds ratio in a 2\u00d72 table","volume":"20","author":"Thomas","year":"1971","journal-title":"Appl Stat"},{"issue":"8775","key":"10.1016\/j.joca.2008.03.001_bib59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0140-6736(91)91975-Z","article-title":"Can meta-analyses be trusted?","volume":"338","author":"Thompson","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.joca.2008.03.001_bib60","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence","volume":"15","author":"Zhang","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.2004.022905","article-title":"Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2004.023028","article-title":"Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.joca.2008.03.001_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/ard.2006.061176","article-title":"Healthcare services for those with musculoskeletal conditions: a rheumatology service. Recommendations of the European Union of Medical Specialists Section of Rheumatology\/European Board of Rheumatology 2006","volume":"66","author":"Woolf","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.joca.2008.03.001_bib64","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.joca.2008.03.001_bib65","article-title":"Acetaminophen for osteoarthritis","volume":"1","author":"Towheed","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.joca.2008.03.001_bib66","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","article-title":"Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis","author":"McAlindon","year":"2000","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.joca.2008.03.001_bib67","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.163.13.1514","article-title":"Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis","volume":"163","author":"Richy","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.joca.2008.03.001_bib68","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.22852","article-title":"The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest","volume":"56","author":"Reginster","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.joca.2008.03.001_bib69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.283.11.1483","article-title":"Glucosamine and chondroitin for treating symptoms of osteoarthritis: evidence is widely touted but incomplete","volume":"283","author":"Towheed","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.joca.2008.03.001_bib70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.11183","article-title":"Current status of glucosamine therapy in osteoarthritis","volume":"49","author":"Towheed","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.joca.2008.03.001_bib71","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/art.22728","article-title":"Glucosamine for pain in osteoarthritis: why do trial results differ?","volume":"56","author":"Vlad","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.joca.2008.03.001_bib72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.joca.2008.03.001_bib73","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jclinepi.2005.12.020","article-title":"Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration","volume":"59","author":"Gagnier","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.joca.2008.03.001_bib74","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1529-0131(200106)45:3<222::AID-ART252>3.0.CO;2-N","article-title":"Use of alternative therapies by older adults with osteoarthritis","volume":"45","author":"Ramsey","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7478","key":"10.1016\/j.joca.2008.03.001_bib75","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","article-title":"Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials","volume":"329","author":"Bjordal","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib76","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.20698","article-title":"A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis","volume":"51","author":"Lee","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2008.03.001_bib77","article-title":"Glucosamine therapy for treating osteoarthritis","volume":"2","author":"Towheed","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.joca.2008.03.001_bib78","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-146-8-200704170-00009","article-title":"Meta-analysis: chondroitin for osteoarthritis of the knee or hip","volume":"146","author":"Reichenbach","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2008.03.001_bib79","doi-asserted-by":"crossref","unstructured":"Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado\/soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007 Nov 23 [Epub ahead of print].","DOI":"10.1016\/j.joca.2007.10.003"},{"issue":"2","key":"10.1016\/j.joca.2008.03.001_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/138945007779940151","article-title":"Antioxidant to treat osteoarthritis: dream or reality?","volume":"8","author":"Henrotin","year":"2007","journal-title":"Curr Drug Targets"},{"issue":"25","key":"10.1016\/j.joca.2008.03.001_bib81","first-page":"2563","article-title":"Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate. A randomized, placebo-controlled cross-over trial in general practice","volume":"165","author":"Jensen","year":"2003","journal-title":"Ugeskr Laeger"},{"issue":"8","key":"10.1016\/j.joca.2008.03.001_bib82","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.joca.2008.03.001_bib83","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.281.9.830","article-title":"The role of meta-analysis in the regulatory process for foods, drugs, and devices","volume":"281","author":"Berlin","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.joca.2008.03.001_bib84","first-page":"1152","article-title":"Direct and indirect costs attributable to osteoarthritis in active subjects","volume":"33","author":"Rabenda","year":"2006","journal-title":"J Rheumatol"},{"issue":"7013","key":"10.1016\/j.joca.2008.03.001_bib85","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.311.7013.1145","article-title":"Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons","volume":"311","author":"Campbell","year":"1995","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.joca.2008.03.001_bib86","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.joca.2008.03.001_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7525-1-17","article-title":"Knee injury and Osteoarthritis Outcome Score (KOOS) \u2013 validation and comparison to the WOMAC in total knee replacement","volume":"1","author":"Roos","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.joca.2008.03.001_bib88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","article-title":"Indexes of severity for osteoarthritis of the hip and knee. Validation \u2013 value in comparison with other assessment tests","volume":"65","author":"Lequesne","year":"1987","journal-title":"Scand J Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.joca.2008.03.001_bib89","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT\u2013OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"issue":"15","key":"10.1016\/j.joca.2008.03.001_bib90","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458408000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458408000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:17:51Z","timestamp":1761016671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458408000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1063458408000654"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2008.03.001","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? \u2013 a meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2008.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}